Subscribe
4
Guo Zhi Fei
Neurosurgery
About me
Graduated from the Clinical Medicine Department of Anhui Medical University in 2004 with a Bachelor's degree in Medicine; obtained a Master's degree in Neurosurgery from Anhui Medical University in 2009; completed a Ph.D. in Clinical Medicine from Anhui Medical University in 2007.
Proficient in diseases
Specializes in cranial trauma, cerebral hemorrhage, intracranial tumors, trigeminal neuralgia, and facial spasms.
Voices
Glioma is a type of disease
Glioma is a very common malignant tumor in the brain, with malignancy levels divided into grades I, II, III, and IV. Grade I has the lowest malignancy, close to benign, and patients have a good prognosis after complete surgical removal. Grade IV gliomas have the highest malignancy and are also known as glioblastomas. These tumors do not have clear boundaries, making complete surgical removal impossible, and they are highly prone to recur after surgery, leading to poor prognosis. Even with the most advanced treatments, such as surgery combined with radiotherapy, chemotherapy, and gene therapy, the average survival time is only 12-14 months, and without treatment, the average survival time is only four months.
Radical treatment method for trigeminal neuralgia
The fundamental cause of trigeminal neuralgia lies in the compression of the trigeminal nerve root by aberrant blood vessels around the area where it exits the brain stem. This compression leads to demyelination of the trigeminal nerve and causes a short circuit in the trigeminal nerve conduction pathway, resulting in trigeminal neuralgia. Currently, the only definitive cure for trigeminal neuralgia is microvascular decompression surgery. This surgery addresses the cause of trigeminal neuralgia by opening the skull, locating the trigeminal nerve and the compressing vessel, and placing a cushion between the nerve and the vessel to achieve a cure. This type of surgery is characterized by minimal trauma, preservation of nerve function, rapid recovery, and low complication rates, making it the best treatment for trigeminal neuralgia that can achieve a definitive cure.
Is a brain infarction dangerous?
The risk associated with a cerebral infarction primarily depends on the extent and location of the infarction. If the infarction is small and located in less critical areas of brain function such as the frontal or temporal lobes, the symptoms may not be severe and might only include dizziness and sleepiness. If the infarction is extensive and occurs in crucial areas such as the basal ganglia, thalamus, or brainstem, the symptoms can be very severe. This could potentially lead to hemiplegia, aphasia, and even coma or death.
Trigeminal neuralgia is divided into several branches.
Trigeminal neuralgia is anatomically divided into three branches: the first branch is the ophthalmic branch, the second branch is the maxillary branch, and the third branch is the mandibular branch. The scope of pain can be used to roughly determine which branch is affected. Generally, pain located in the forehead area is caused by the first branch, the ophthalmic branch. Pain in the area from the tip of the nose to the lips is caused by the second branch, the maxillary branch. Pain from the lips to the angle of the jaw is caused by the third branch, the mandibular branch. Therefore, we can understand which branch is in pain by the distribution area and scope of the trigeminal neuralgia.